克唑替尼 Crizotinib Crizotinib, also known as PF-02341066, is an orally bioavailable agent belonging to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
厄洛替尼/埃羅替尼 Erlotinib Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved.
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
阿法替尼 Afatinib Afatinib, also know as BIBW 2992, is an orally bioavailable dual receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
人PSA-NCAM陽(yáng)性(PSA-NCAM+)神經(jīng)細胞 Human neural progenitor cells (PSA-NCAM+) are derived from whole brain that are quickly dissociated into single cells and cultured.
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
微信掃一掃